<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="article-commentary"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Aesthet Surg J</journal-id><journal-id journal-id-type="iso-abbrev">Aesthet Surg J</journal-id><journal-id journal-id-type="publisher-id">AES</journal-id><journal-id journal-id-type="hwp">spaes</journal-id><journal-title-group><journal-title>Aesthetic Surgery Journal</journal-title></journal-title-group><issn pub-type="ppub">1090-820X</issn><issn pub-type="epub">1527-330X</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage CA: Los Angeles, CA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23515384</article-id><article-id pub-id-type="pmc">3667690</article-id><article-id pub-id-type="doi">10.1177/1090820X13478971</article-id><article-id pub-id-type="publisher-id">10.1177_1090820X13478971</article-id><article-categories><subj-group subj-group-type="heading"><subject>Body Contouring</subject><subj-group subj-group-type="heading"><subject>Commentary</subject></subj-group></subj-group></article-categories><title-group><article-title>Commentary on: Metabolic and Structural Effects of
Phosphatidylcholine and Deoxycholate Injections on Subcutaneous Fat: A
Randomized, Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Duncan</surname><given-names>Diane</given-names></name><degrees>MD</degrees></contrib><aff id="aff1-1090820X13478971">Dr Duncan is a plastic surgeon in private practice
in Fort Collins, Colorado</aff></contrib-group><author-notes><corresp id="corresp1-1090820X13478971">Dr Diane Duncan, 1701 East Prospect Rd, Fort
Collins, CO 80525, USA. E-mail: <email>momsurg@aol.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>3</month><year>2013</year></pub-date><!--Fake ppub date generated  by PMC from publisher pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>3</month><year>2013</year></pub-date><volume>33</volume><issue>3</issue><fpage>411</fpage><lpage>413</lpage><permissions><copyright-statement>&#x000a9; 2013 The American Society for Aesthetic Plastic Surgery,
Inc.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder content-type="society">American Society for Aesthetic Plastic
Surgery, Inc.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/2.5/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits non-commercial use, distribution,
and reproduction in any medium, provided the original work is properly
cited.</license-p></license></permissions></article-meta></front><body><p>In their article entitled, &#x0201c;Metabolic and Structural Effects of Phosphatidylcholine and
Deoxycholate Injections on Subcutaneous Fat: A Randomized, Controlled Trial,&#x0201d; Reeds et
al analyzed the effects of phosphatidylcholine and deoxycholate (PC-DC) treatments on
body composition, adipocyte function, and mechanisms responsible for fat loss. Thirteen
women were enrolled; only 7 completed the study. This small sample size renders
statistically significant calculations virtually impossible.</p><p>The authors maintain that PC-DC injections have become increasingly popular. This may be
true in Seoul, Korea, where over 6000 vials of Lipobean<sup><xref ref-type="bibr" rid="bibr1-1090820X13478971">1</xref></sup> are injected monthly into human subcutaneous fat for the purpose of fat
reduction. However, in many countries around the world, the practice of injection
lipolysis has been banned.<sup><xref ref-type="bibr" rid="bibr2-1090820X13478971">2</xref></sup> Popularity of these injections in the United States has dwindled,<sup><xref ref-type="bibr" rid="bibr3-1090820X13478971">3</xref></sup> in part due to the lack of a US Food and Drug Administration (FDA)&#x02013;approved agent
and also due to the lack of efficacy in treating larger body regions.<sup><xref ref-type="bibr" rid="bibr4-1090820X13478971">4</xref></sup> The side effects, although not morbid, are unpleasant. Noninvasive treatments
such as Liposonix (Solta Medical, Inc, Bothell, Washington) and Tite FX (Invasix,
Richmond Hill, Ontario, Canada)<sup><xref ref-type="bibr" rid="bibr5-1090820X13478971">5</xref>,<xref ref-type="bibr" rid="bibr6-1090820X13478971">6</xref></sup> offer much more fat reduction without the cholinergic side effects that can be
seen with higher-dose PC-DC injections.</p><p>Despite the shortcomings of injection lipolysis as currently practiced, there has been a
resurgence of interest in the topic,<sup><xref ref-type="bibr" rid="bibr7-1090820X13478971">7</xref></sup> especially in Europe and Asia. There are many reasons for this, including the
expansion of the practice of aesthetic medicine and the desire of practitioners who
mainly perform injections to have an injectable solution for reduction of protrusions.
If aesthetic practitioners can fill hollow regions, they may also want to reduce or take
away volume. The ability to do this precisely with an injection would be an excellent
addition to the cosmetic injector&#x02019;s options.</p><p>The mechanism of action of PC-DC injections has been explored by several investigators,
although none employed the breadth of testing presented in this study. The conjecture by
Rotunda et al<sup><xref ref-type="bibr" rid="bibr8-1090820X13478971">8</xref></sup> that the detergent effect of sodium deoxycholate was the mechanism of action of
the drug was confirmed in a study done by Duncan et al in 2009.<sup><xref ref-type="bibr" rid="bibr9-1090820X13478971">9</xref></sup> In this stem cell study, PC, normally solubilized in DC, was isolated and
solubilized in inert mineral oil. Two cytotoxicity assays and 2 lipolytic assays were
performed on the differentiated adipocytes. Solutions tested included PC alone,
PC50-DC42, 2 concentrations of deoxycholate, the benzyl alcohol preservative, and a
saline control. Phosphatidylcholine alone had no cytotoxic or lipolytic effect; the
readings were equivalent to the saline control. Deoxycholate had a dose-dependent
cytotoxic and lipolytic effect. Benzyl alcohol had no cytotoxic or lipolytic effect.</p><p>Interestingly, the histologic presence of &#x0201c;crown-like structures&#x0201d; is a marker for
adipocyte inflammation and death in metabolic syndrome<sup><xref ref-type="bibr" rid="bibr10-1090820X13478971">10</xref>,<xref ref-type="bibr" rid="bibr11-1090820X13478971">11</xref></sup>; it is not a hallmark specific to injection lipolysis. Apoptosis is present in
human adults as a normal occurrence. More than 50 billion cells die an apoptotic death
on a daily basis in most adults.<sup><xref ref-type="bibr" rid="bibr12-1090820X13478971">12</xref></sup> The caspase markers measured in this study show a decrease of caspase-3 on both
the control side and the treated side at 8 weeks. Caspase-3 levels measure cells killed
by this effector enzyme.<sup><xref ref-type="bibr" rid="bibr13-1090820X13478971">13</xref></sup> A low level of caspase-3 would indicate that little to no actual apoptotic cell
death had occurred.</p><p>Many authors note the presence of cell wall lysis<sup><xref ref-type="bibr" rid="bibr14-1090820X13478971">14</xref><xref ref-type="bibr" rid="bibr15-1090820X13478971"/>-<xref ref-type="bibr" rid="bibr16-1090820X13478971">16</xref></sup>&#x02014;an event not present with apoptosis&#x02014;in their histologic evaluation of the tissue
reaction to injection lipolysis. The toxic tissue injury caused by PC-DC injections
causes an overwhelming oncotic effect. Commonly known as &#x0201c;necrosis,&#x0201d; tissue oncosis is
caused by an inflammatory event or injury causing loss of cell respiration due to oxygen deprivation.<sup><xref ref-type="bibr" rid="bibr17-1090820X13478971">17</xref></sup> The strong response of swelling, pain, and inflammation&#x02014;signs of an oncotic
reaction&#x02014;is clear in patients who receive the treatment. Pyroptosis<sup><xref ref-type="bibr" rid="bibr18-1090820X13478971">18</xref></sup> is a caspase-1&#x02013;mediated mechanism of cell death that has features of both
apoptosis and oncosis. Tissue aspirate may not provide an adequate specimen for
apoptosis evaluation; cell distortion&#x02014;especially of adipocytes&#x02014;can mask the membrane
blebs, pyknotic nuclei, cell shrinkage, and tissue collapse pattern seen with true apoptosis.<sup><xref ref-type="bibr" rid="bibr19-1090820X13478971">19</xref></sup> Although both apoptosis and pyroptosis may be present&#x02014;and it would have been
interesting to see the caspase-1 levels in the present study&#x02014;the evidence is
overwhelming that toxin-induced tissue necrosis is the mechanism of the PC-DC
effect.</p><p>The detergent effect on cell membranes has been extensively studied by protein chemists.<sup><xref ref-type="bibr" rid="bibr20-1090820X13478971">20</xref></sup> Detergents are amphipathic molecules, having a hydrophilic tail and a hydrophobic
head. An ionic detergent such as deoxycholate inserts or &#x0201c;partitions&#x0201d; into the cell
membrane and denatures proteins. At a lower dose of deoxycholate, the cell membrane
undergoes poration and becomes &#x0201c;leaky.&#x0201d; At a higher concentration, the detergent effect
causes micelle formation, with subsequent cell wall lysis.<sup><xref ref-type="bibr" rid="bibr21-1090820X13478971">21</xref></sup> The addition of PC to the formula causes liposome formation rather than micelle formation.<sup><xref ref-type="bibr" rid="bibr22-1090820X13478971">22</xref></sup>
</p><p>Histologic effects of PC-DC injections and DC injections have appeared in the literature
since 2004.<sup><xref ref-type="bibr" rid="bibr7-1090820X13478971">7</xref></sup> Rotunda et al<sup><xref ref-type="bibr" rid="bibr8-1090820X13478971">8</xref></sup> noted necrosis of adipocytes in porcine tissue, as well as death of skeletal
muscle cells. Rose and Morgan<sup><xref ref-type="bibr" rid="bibr23-1090820X13478971">23</xref></sup> noted in his human biopsies that adipocyte necrosis was present at 1 week and 2
weeks following injection. The 30-patient study by Yagima Odo et al<sup><xref ref-type="bibr" rid="bibr24-1090820X13478971">24</xref></sup> showed adipocyte lysis with inflammation and phagocytosis by macrophages.
Schuller-Petrovic et al<sup><xref ref-type="bibr" rid="bibr25-1090820X13478971">25</xref></sup> concurred and noted dose-dependent fibroplasia in histologic specimens, as well
as muscle loss and necrotic changes in the walls of small blood vessels.</p><p>The lack of tissue specificity of the PC-DC injections, or DC injections alone, is a
safety concern first raised by Rotunda et al in 2004.<sup><xref ref-type="bibr" rid="bibr8-1090820X13478971">8</xref></sup> Gupta et al<sup><xref ref-type="bibr" rid="bibr26-1090820X13478971">26</xref></sup> performed a tetrazolium bromide assay on different tissue types to assess the
cytotoxic effect of PC-DC or DC alone on preadipocytes, fibroblasts, endothelial cells,
and muscle cells at 1, 2, and 3 days. The group reported similar kill rates for all cell
types, showing nearly 100% cell lysis at 24 hours. Their conclusion was that these
compounds act in a &#x0201c;nonspecific manner&#x0201d; and therefore may be unsafe if unintentionally
injected in the wrong location.</p><p>These changes occur over time, as noted by Duncan and Golitz<sup><xref ref-type="bibr" rid="bibr27-1090820X13478971">27</xref></sup> in a serial histology study performed in 2008. Biopsies were taken at 1 week, 2
weeks, and 8 weeks following patient treatment with a saline control, PC50-DC42, and DC
24 mg/mL alone. The DC solutions showed immediate cell wall lysis with ground substance
formation and extensive necrosis at 1 day, with fibrosis at 2 weeks and extensive
fibrosis at 8 weeks. In contrast, the onset of cell wall lysis was delayed in the PC-DC
specimen and was not visible until 2 weeks postinjection. Inflammatory changes with
PC-DC were noted in the fibroseptal region, but no extensive fibrosis was noted.</p><p>In that same study, Duncan and Golitz<sup><xref ref-type="bibr" rid="bibr27-1090820X13478971">27</xref></sup> noted that a phenomenon called &#x0201c;necrobiosis&#x0201d; occurred at 8 weeks in the deep
reticular dermis of the deoxycholate-injected specimen. The deep layer of the dermis&#x02014;not
initially injected during treatment&#x02014;was noted to have a bluish cast to the normally pink
collagen of the reticular dermal layer. This was accompanied by thickening and sclerosis
of the blood vessels, with a similar pattern noted in eccrine glands and hair follicles.
These findings, in addition to patient intolerance of injection-associated pain,
swelling, and bruising, have led to the reduction in the concentration of PC-DC; in
Europe and in Korea, the most commonly injected formula is PC25-DC12.</p><p>New uses for injection lipolysis include very small amounts of dilute PC-DC for reduction
of facial features such as cheeks, nasolabial folds, marionette &#x0201c;poufs,&#x0201d; and malar bags
(M. Palmer, personal communication, January 2012). Choi<sup><xref ref-type="bibr" rid="bibr28-1090820X13478971">28</xref></sup> has shown excellent results in reducing supraorbital fatty bulges in Asian
patients. Veterinary use includes treatment of surgically unresectable infiltrating
lipomas in canines (J. Ludlow, personal communication to M. Palmer, December 2012).</p><p>The magnetic resonance imaging findings by Reeds et al are irrefutable; injections of PC
and DC do indeed work for subcutaneous fat reduction. Initially quite popular, these
treatments have lost favor due to the pain and downtime associated with the injections,
the lack of an FDA-approved drug, and the lack of a tissue-specific response to these
injections. As the popularity of aesthetic medicine grows, an increasing number of
noncore practitioners will be performing cosmetic injections. Although efficacious, the
lack of tissue specificity of PC-DC injections creates a concern regarding long-term
safety when the drug is injected by untrained practitioners.</p></body><back><fn-group><fn fn-type="conflict"><p><bold>Disclosures:</bold> The author declared no potential conflicts of interest with respect to the
research, authorship, and publication of this article.</p></fn></fn-group><ref-list><title>References</title><ref id="bibr1-1090820X13478971"><label>1.</label><mixed-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Jeong</surname><given-names>ES</given-names></name></person-group>
<article-title>Clinical use of phosphatidylcholine/deoxycho
late in a Seoul, Korea obesity clinic</article-title>. <conf-name>Presented
at: PC/DC Workshop, MIPS</conf-name>; <conf-date>September 1,
2012</conf-date>; <conf-loc>Seoul, Korea</conf-loc></mixed-citation></ref><ref id="bibr2-1090820X13478971"><label>2.</label><mixed-citation publication-type="webpage">
<collab>Non-surgical lipolysis banned in France</collab>
<ext-link ext-link-type="uri" xlink:href="http://www.consultingroom.com/blog/184/non-surgical-lipolysis-banned-in-france">http://www.consultingroom.com/blog/184/non-surgical-lipolysis-banned-in-france</ext-link>
<date-in-citation>Accessed January 2, 2013</date-in-citation></mixed-citation></ref><ref id="bibr3-1090820X13478971"><label>3.</label><mixed-citation publication-type="webpage">
<collab>Laddy S. Masterpharm Bulletin</collab>
<ext-link ext-link-type="uri" xlink:href="http://www.masterpharm.com">http://www.masterpharm.com</ext-link>
<month>4</month>
<day>12</day>, <year>2012</year></mixed-citation></ref><ref id="bibr4-1090820X13478971"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Palmer</surname><given-names>M</given-names></name><name><surname>Curran</surname><given-names>J</given-names></name><name><surname>Bowler</surname><given-names>P</given-names></name></person-group>
<article-title>Clinical experience and safety using
phosphatidylcholine injections for the localized reduction of subcutaneous
fat: a multicenter, retrospective UK study</article-title>. <source>J Cosmet
Dermatol</source>.
<year>2006</year>;<volume>5</volume>:<fpage>218</fpage>-<lpage>226</lpage><pub-id pub-id-type="pmid">17177743</pub-id></mixed-citation></ref><ref id="bibr5-1090820X13478971"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gadsden</surname><given-names>E</given-names></name><name><surname>Aguilar</surname><given-names>MT</given-names></name><name><surname>Smoller</surname><given-names>BR</given-names></name><name><surname>Jewell</surname><given-names>MT</given-names></name></person-group>
<article-title>Evaluation of a novel high-intensity focused
ultrasound device for ablating subcutaneous adipose tissue for noninvasive
body contouring; safety studies in human volunteers</article-title>.
<source>Aesthetic Surg J</source>.
<year>2011</year>;<volume>31</volume>(<issue>4</issue>):<fpage>401</fpage>-<lpage>410</lpage></mixed-citation></ref><ref id="bibr6-1090820X13478971"><label>6.</label><mixed-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Mulholland</surname><given-names>S</given-names></name></person-group>
<article-title>Electroporation effect of radiofrequency based
energy assisted noninvasive fat reduction using the Tite FX
device</article-title>. <conf-name>Presented at: IMCAS Asia</conf-name>;
<conf-date>October 4-6, 2012</conf-date>; <conf-loc>Hong
Kong</conf-loc></mixed-citation></ref><ref id="bibr7-1090820X13478971"><label>7.</label><mixed-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Duncan</surname><given-names>D</given-names></name></person-group>
<article-title>Current status of injection
lipolysis</article-title>. <conf-name>Presented at: IMCAS Asia</conf-name>;
<conf-date>October 4-6, 2012</conf-date>; <conf-loc>Hong
Kong</conf-loc></mixed-citation></ref><ref id="bibr8-1090820X13478971"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rotunda</surname><given-names>A</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Moy</surname><given-names>RL</given-names></name><name><surname>Kolodney</surname><given-names>MS</given-names></name></person-group>
<article-title>Detergent effects of sodium deoxycholate are a
major feature of an injectable phosphatidylcholine formula used for
localized fat dissolution</article-title>. <source>Dermatol Surg</source>.
<year>2004</year>;<volume>30</volume>(<issue>7</issue>):<fpage>1001</fpage>-<lpage>1008</lpage><pub-id pub-id-type="pmid">15209790</pub-id></mixed-citation></ref><ref id="bibr9-1090820X13478971"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duncan</surname><given-names>D</given-names></name><name><surname>Rubin</surname><given-names>JP</given-names></name><name><surname>Golitz</surname><given-names>L</given-names></name><name><surname>Badylak</surname><given-names>S</given-names></name><name><surname>Kesel</surname><given-names>L</given-names></name><name><surname>Duncan</surname><given-names>D</given-names></name></person-group>
<article-title>Refinement of technique in injection lipolysis
based on scientific studies and clinical evaluation</article-title>.
<source>Clin Plast Surg</source>.
<year>2009</year>;<volume>36</volume>(<issue>2</issue>):<fpage>195</fpage>-<lpage>209</lpage>,
v-vi; discussion 211-213.<pub-id pub-id-type="pmid">19309643</pub-id></mixed-citation></ref><ref id="bibr10-1090820X13478971"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Altintas</surname><given-names>M</given-names></name><name><surname>Azad</surname><given-names>A</given-names></name><name><surname>Nayer</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Mast cells, macrophages, and crown-like
structures distinguish subcutaneous from visceral fat in
mice</article-title>. <source>J Lipid Res</source>.
<year>2011</year>;<volume>52</volume>(<issue>3</issue>):<fpage>480</fpage>-<lpage>488</lpage><pub-id pub-id-type="pmid">21148461</pub-id></mixed-citation></ref><ref id="bibr11-1090820X13478971"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aporian</surname><given-names>C</given-names></name><name><surname>Bigiorna</surname><given-names>S</given-names></name><name><surname>Mott</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Adipose macrophage infiltration is associated
with insulin resistance and vascular endothelial dysfunction in obese
patients</article-title>. <source>Arterioscler Thromb Vasc Biol</source>.
<year>2008</year>;<volume>28</volume>:<fpage>1654</fpage>-<lpage>1659</lpage><pub-id pub-id-type="pmid">18566296</pub-id></mixed-citation></ref><ref id="bibr12-1090820X13478971"><label>12.</label><mixed-citation publication-type="webpage">
<collab>Apoptosis</collab>
<ext-link ext-link-type="uri" xlink:href="http://www.wikipedia.org/wiki/apoptosis">www.wikipedia.org/wiki/apoptosis</ext-link>
<date-in-citation>Accessed January
2, 2013</date-in-citation></mixed-citation></ref><ref id="bibr13-1090820X13478971"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Porter</surname><given-names>AG</given-names></name><name><surname>J&#x000e4;nicke</surname><given-names>RU</given-names></name></person-group>
<article-title>Emerging roles of caspase-3 in
apoptosis</article-title>. <source>Cell Death Differ</source>.
<year>1999</year>;<volume>6</volume>(<issue>2</issue>):<fpage>99</fpage>-<lpage>104</lpage>
<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/cdd/journal/v6/n2/abs/4400476a.html">http://www.nature.com/cdd/journal/v6/n2/abs/4400476a.html</ext-link>
<date-in-citation>Accessed January 2, 2013</date-in-citation><pub-id pub-id-type="pmid">10200555</pub-id></mixed-citation></ref><ref id="bibr14-1090820X13478971"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bechara</surname><given-names>FG</given-names></name><name><surname>Sand</surname><given-names>M</given-names></name><name><surname>Sand</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Lipolysis of lipomas in patients with familial
multiple lipomatosis: an ultrasonography-controlled clinical
trial</article-title>. <source>J Cutan Med Surg</source>.
<year>2006</year>;<volume>10</volume>(<issue>4</issue>):<fpage>155</fpage>-<lpage>159</lpage><pub-id pub-id-type="pmid">17234112</pub-id></mixed-citation></ref><ref id="bibr15-1090820X13478971"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duncan</surname><given-names>D</given-names></name><name><surname>Rotunda</surname><given-names>A</given-names></name></person-group>
<article-title>Injectable therapies for localized fat loss:
state of the art</article-title>. <source>Clin Plast Surg</source>.
<year>2011</year>;<volume>38</volume>(<issue>3</issue>):<fpage>489</fpage>-<lpage>501</lpage><pub-id pub-id-type="pmid">21824545</pub-id></mixed-citation></ref><ref id="bibr16-1090820X13478971"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kopera</surname><given-names>D</given-names></name><name><surname>Horejsi</surname><given-names>R</given-names></name><name><surname>Werner</surname><given-names>S</given-names></name><name><surname>Moeller</surname><given-names>R</given-names></name></person-group>
<article-title>Injection lipolysis for reduction of saddlebag
trochanteric bulges&#x02014;half side controlled pilot study</article-title>.
<source>J Dtsch Dermatol Ges</source>.
<year>2008</year>;<volume>6</volume>(<issue>4</issue>):<fpage>287</fpage>-<lpage>290</lpage><pub-id pub-id-type="pmid">18081857</pub-id></mixed-citation></ref><ref id="bibr17-1090820X13478971"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Majno</surname><given-names>G</given-names></name><name><surname>Joris</surname><given-names>I</given-names></name></person-group>
<article-title>Apoptosis, oncosis, and necrosis: an overview of
cell death</article-title>. <source>Am J Pathol</source>.
<year>1995</year>;<volume>146</volume>(<issue>1</issue>):<fpage>3</fpage>-<lpage>15</lpage><pub-id pub-id-type="pmid">7856735</pub-id></mixed-citation></ref><ref id="bibr18-1090820X13478971"><label>18.</label><mixed-citation publication-type="webpage">
<person-group person-group-type="author"><name><surname>Bergsbaker</surname><given-names>T</given-names></name><name><surname>Fink</surname><given-names>S</given-names></name><name><surname>Cookson</surname><given-names>B</given-names></name></person-group>
<article-title>Pyroptosis: host cell death and
inflammation</article-title>. <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/nrmicro/journal/v7/n2/abs/nrmicro207">http://www.nature.com/nrmicro/journal/v7/n2/abs/nrmicro207</ext-link>
<date-in-citation>Accessed January 2, 2013</date-in-citation></mixed-citation></ref><ref id="bibr19-1090820X13478971"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elmore</surname><given-names>S</given-names></name></person-group>
<article-title>Apoptosis: a review of programmed cell
death</article-title>. <source>Toxicol Pathol</source>.
<year>2007</year>;<volume>35</volume>(<issue>4</issue>):<fpage>495</fpage>-<lpage>516</lpage><pub-id pub-id-type="pmid">17562483</pub-id></mixed-citation></ref><ref id="bibr20-1090820X13478971"><label>20.</label><mixed-citation publication-type="webpage">
<collab>Thermo Scientific</collab>
<ext-link ext-link-type="uri" xlink:href="http://www.piercenet.com">www.piercenet.com</ext-link>
<date-in-citation>Accessed
January 2, 2013</date-in-citation></mixed-citation></ref><ref id="bibr21-1090820X13478971"><label>21.</label><mixed-citation publication-type="webpage">
<collab>Micelles</collab>
<ext-link ext-link-type="uri" xlink:href="http://www.elmhurst.edu/~chm/vchembook/558micelle.html">www.elmhurst.edu/~chm/vchembook/558micelle.html</ext-link>
<date-in-citation>Accessed January 2, 2013</date-in-citation></mixed-citation></ref><ref id="bibr22-1090820X13478971"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wowra</surname><given-names>B</given-names></name><name><surname>Cremer</surname><given-names>K</given-names></name><name><surname>Stricker</surname><given-names>H</given-names></name><name><surname>Zeller</surname><given-names>WJ</given-names></name></person-group>
<article-title>Intraneoplastic application of
metrizamide-containing liposomes: kinetic studies with computed
tomography</article-title>. <source>J Neurooncol</source>.
<year>1992</year>;<volume>14</volume>(<issue>1</issue>):<fpage>9</fpage>-<lpage>18</lpage><pub-id pub-id-type="pmid">1469468</pub-id></mixed-citation></ref><ref id="bibr23-1090820X13478971"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rose</surname><given-names>PT</given-names></name><name><surname>Morgan</surname><given-names>M</given-names></name></person-group>
<article-title>Histological changes associated with mesotherapy
for fat dissolution</article-title>. <source>J Cosmet Laser Ther</source>.
<year>2005</year>;<volume>7</volume>(<issue>1</issue>):<fpage>17</fpage>-<lpage>19</lpage><pub-id pub-id-type="pmid">16020211</pub-id></mixed-citation></ref><ref id="bibr24-1090820X13478971"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yagima Odo</surname><given-names>ME</given-names></name><name><surname>Cuce</surname><given-names>LC</given-names></name><name><surname>Odo</surname><given-names>LM</given-names></name><name><surname>Natrielli</surname><given-names>A</given-names></name></person-group>
<article-title>Action of sodium deoxycholate on subcutaneous
human tissue: local and systemic effects</article-title>. <source>Dermatol
Surg</source>.
<year>2007</year>;<volume>33</volume>(<issue>2</issue>):<fpage>178</fpage>-<lpage>188</lpage><pub-id pub-id-type="pmid">17300603</pub-id></mixed-citation></ref><ref id="bibr25-1090820X13478971"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schuller-Petrovic</surname><given-names>S</given-names></name><name><surname>Wolkart</surname><given-names>G</given-names></name><name><surname>Hofler</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Tissue-toxic effects of
phosphatidylcholine/deoxycholate after subcutaneous injection for fat
dissolution in rats and a human volunteer</article-title>. <source>Dermatol
Surg</source>.
<year>2008</year>;<volume>34</volume>(<issue>4</issue>):<fpage>529</fpage>-<lpage>542</lpage><pub-id pub-id-type="pmid">18370980</pub-id></mixed-citation></ref><ref id="bibr26-1090820X13478971"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Lobocki</surname><given-names>C</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Actions and comparative efficacy of
phosphatidylcholine formulation and isolated sodium deoxycholate for
different cell types</article-title>. <source>Aesthetic Plast Surg</source>.
<year>2009</year>;<volume>33</volume>(<issue>3</issue>):<fpage>346</fpage>-<lpage>352</lpage><pub-id pub-id-type="pmid">19198927</pub-id></mixed-citation></ref><ref id="bibr27-1090820X13478971"><label>27.</label><mixed-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Duncan</surname><given-names>D</given-names></name><name><surname>Golitz</surname><given-names>L</given-names></name></person-group>
<article-title>Tissue toxic effects of sodium deoxycholate
dominant formulas for injection lipolysis</article-title>.
<conf-name>Presented at: FSPS Annual Meeting</conf-name>;
<conf-date>December 5, 2008</conf-date>; <conf-loc>Palm Beach,
FL</conf-loc></mixed-citation></ref><ref id="bibr28-1090820X13478971"><label>28.</label><mixed-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Choi</surname><given-names>H</given-names></name></person-group>
<article-title>Use of Lipobean formula for reduction of
excessive subcutaneous fat in the Asian face</article-title>.
<conf-name>Presented at: MIPS Conference</conf-name>; <conf-date>September
1, 2012</conf-date>; <conf-loc>Seoul, Korea</conf-loc></mixed-citation></ref></ref-list></back></article>